Biocon

Type: Company
Name: Biocon
First reported May 23 2013 - Updated 10 hours ago - 1 reports

Forbes lists Sonia Gandhi, Nooyi among 10 most powerful women

Congress President Sonia Gandhi and India-born PepsiCo chief Indra Nooyi figure among the top 10 in the global list of most powerful women compiled by Forbes magazine for 2013.Gandhi is ranked ninth while Nooyi is at the tenth place in the global list ... [Published India Today - May 23 2013]
First reported 13 hours ago - Updated 13 hours ago - 1 reports

High hopes of CM and Congress making Bangalore better (Karnataka Newsletter)

Bangalore, May 24 (IANS) Karnataka Chief Minister Siddaramaiah seems to have raised hopes of better times for this capital as he has kept with himself the Bangalore and IT departments, apart from his pet subject - finance."It is a good move," T. V. Mohandas ... [Published Sify - 13 hours ago]
First reported May 22 2013 - Updated May 23 2013 - 8 reports

Sonia Gandhi, Indra Nooyi among 10 most powerful women globally: Forbes

ReutersNew York: Congress President Sonia Gandhi and India-born PepsiCo Chief Indra Nooyi figure among the top 10 in the global list of most powerful women compiled by Forbes magazine for 2013.Gandhi is ranked ninth while Nooyi is at the 10th place in ... [Published msn.co.in - May 23 2013]
First reported May 22 2013 - Updated May 22 2013 - 1 reports

Mylan: Brand/Generic Distinction Disintegration Is Necessary

Consolidation in the generic industry is good and necessary, Mylan CEO Heather Bresch said during a recent investor presentation. Mylan is well-positioned in the changing market, she said, thanks to business development such as its biosimilars agreements ... [Published The Rose Sheet - May 22 2013]
First reported May 22 2013 - Updated May 22 2013 - 1 reports

Biocon hopes sales of biosimilars will triple

Biocon is upbeat about its biosimilars. The leading biopharmaceutical company expects the sales revenue from this segment to treble by FY15. It hopes the patent expiry of eight of the top 10 biotech products by 2018 will boost the Indian generics market. ... [Published Financial Chronicle - May 22 2013]
Entities: Biocon, Phase III, Biology, India
First reported May 22 2013 - Updated May 22 2013 - 1 reports

Biotech industry faces threat from delays in clinical trials

Studies project a promising future for the biotechnology industry and predict that it has the potential to grow to a $100 billion industry by 2025. However, the existing regulatory ecosystem and the procedural delays in clinical trials are major hurdles ... [Published Financial Chronicle - May 22 2013]
First reported May 22 2013 - Updated May 22 2013 - 1 reports

UPA II best remembered for wrong reasons

Finance minister P Chidambaram in the Budget for 2013-14 unveiled plans to reduce India’s fiscal deficit to 3% of GDP in five years, demonstrating the government’s intent to walk the talk on fiscal discipline. |PTI File photoThe last leg of the United ... [Published New Indian Express - May 22 2013]
First reported May 20 2013 - Updated May 21 2013 - 2 reports

Market off day's high; Nifty trades below 6,200

Source: IRIS (20-MAY-13)Comments | Post CommentIndian equities still trading in the positive terrain in the post noon trade on Monday with some buying interest seen in auto, realty and metal stocks. However, consumer durables, healthcare and oil & gas ... [Published MyIris - May 20 2013]
First reported May 21 2013 - Updated May 21 2013 - 1 reports

Bilcare secures Biocon export, offers track-n-trace and authentication technology

Bilcare, India's leading innovation-driven technology solution company has been associated with Biocon, country's largest biopharma company, to provide secure, non-clonable 'Track & Trace technology' for protection of Biocon's exports across globe.Mumbai, ... [Published IndiaPRwire - May 21 2013]
First reported May 20 2013 - Updated May 20 2013 - 1 reports

BIOCON, Growth Drivers - Long Term and Uncertain, Expenses - Near Term and Certain - new market research report

Q3FY13 result of Biocon was moderately better than our estimates. Revenue of the company grew by 24% and EBITDA grew by 18% Y-o-Y. The quarterly outperformance was largely on account of improved performance of Biopharma (ex-licensing income) driven by ... [Published TransWorldNews - May 20 2013]
Entities: Biocon, Insulin, Lipitor
First reported May 17 2013 - Updated May 18 2013 - 2 reports

Sensex ends slightly higher; power, capital goods jump

Indian equities settled marginally higher on Friday. Power, capital goods, realty and banking stocks gained ground. At the close, the benchmark 30-share index, BSE Sensex gained 38.79 or 0.19% at 20,286.12 with 16 components registering rise. Meanwhile, ... [Published MyIris - May 17 2013]
First reported May 17 2013 - Updated May 17 2013 - 1 reports

Bilcare secures Biocon export

Offers track and trace and authentication technologyBilcare has been associated with Biocon to provide secure, non-clonable track and trace technology for protection of Biocon's exports across globe. Bilcare is providing end-to-end holistic solutions ... [Published Express Pharma - May 17 2013]

Quotes

Rakesh Goel, senior vice president, Bonanza Portfolio said, "Weekly candlestick chart pattern is indicating bearish formation and further selling is likely in coming week below 5,935 levels. Also, on the upsides, 6,050-6,100 shall be strong resistance area and sell on rallies is likely. In coming week, 5,935 shall be crucial deciding level in near term, and index is likely to witness further selling below this level. Below 5,935, likely target is 5,850-5,830, while above 6,025, likely target is 6,050-6,100."
...On B PAC's expectation from the new government, Pai said: "Good governance, transparency in administration, no corruption and development of Bangalore on a war footing."
The actual fiscal deficit for 2012-13 is likely to be lower than earlier estimates of 5.2%, with the government managing to achieve the ` "10,38,037-crore tax target for 2012-13"
..."Within a few years," says Aditya Mathur, professor at SUTD, "students get intensely trained to solve problems of the future." At SUTD, architecture is a core discipline for everybody

More Content

All (204) | News (196) | Reports (1) | Blogs (5) | Audio/Video (1) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
Sensex ends 30 points higher; Tata Steel surges [Published MyIris - 9 hours ago]
Sensex trades marginally higher; Tata Steel surges [Published MyIris - 11 hours ago]
High hopes of CM and Congress making Bangalore ... [Published Sify - 13 hours ago]
High hopes of CM and Congress making Bangalore ... [Published ProKerala.com - 13 hours ago]
Forbes lists Sonia Gandhi, Nooyi among 10 most ... [Published India Today - May 23 2013]
Gandhi ninth Nooyi 10th in Forbes' world's 100 ... [Published KeralaNext.com - May 23 2013]
Sonia Gandhi, Indra Nooyi among 10 most powerfu... [Published msn.co.in - May 23 2013]
Sonia, Nooyi among Forbes 10 powerful women glo... [Published IBNLive India News - May 23 2013]
'Sonia Gandhi, Nooyi among 10 most powerful wom... [Published Deccan Herald - May 23 2013]
Sonia Gandhi, Nooyi among 10 most powerful wome... [Published Moneycontrol.com - May 23 2013]
Sonia Gandhi, Nooyi among Indians in Forbes wor... [Published TruthDive - May 23 2013]
Mylan: Brand/Generic Distinction Disintegration... [Published The Rose Sheet - May 22 2013]
Sonia, Nooyi among 10 most powerful women [Published Financial Chronicle - May 22 2013]
Biocon hopes sales of biosimilars will triple [Published Financial Chronicle - May 22 2013]
‘Sonia Gandhi, Indra Nooyi among 10 most powerf... [Published Firstpost.com - May 22 2013]
'Sonia Gandhi, Nooyi among 10 most powerful wom... [Published zeenews.com - May 22 2013]
Biotech industry faces threat from delays in cl... [Published Financial Chronicle - May 22 2013]
UPA II best remembered for wrong reasons [Published New Indian Express - May 22 2013]
Bilcare secures Biocon export, offers track-n-t... [Published IndiaPRwire - May 21 2013]
India pharmaceuticals market: 18% growth betwee... [Published TransWorldNews - May 20 2013]
Sensors and RFID: Engineers of tomorrow will le... [Published CL2M Next Generation PLM - May 20 2013]
Nifty may test 6330 in near term: Sandeep Wagle... [Published Economic Times - May 20 2013]
Market off day's high; Nifty trades below 6,200 [Published MyIris - May 20 2013]
Competitor Analysis: Thrombolytics & Fibrinolytics [Published Individual.com - May 20 2013]
BIOCON, Growth Drivers - Long Term and Uncertai... [Published TransWorldNews - May 20 2013]
Sensex gains nearly 150 points; Nifty trades ab... [Published MyIris - May 20 2013]
City scores low on medical tourism [Published New Indian Express - May 19 2013]
Investors make gains amid high volatility [Published Smart Investor - May 19 2013]
Pharmaceutical sector shares fall after price c... [Published Topnews.in - May 18 2013]
Bilcare secures Biocon export [Published Express Pharma - May 17 2013]
1 2 3 4 5 6 7
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Deals Of The Week Notes Bayer's Partnerships Ar... [Published The IN VIVO Blog - Feb 15 2013]
Bayer Healthcare’s pharmaceuticals division has certainly had its ups and downs, and some ultra-tense relationships with partners—notably the very public lawsuit Onyx Pharmaceuticals filed against it, which the partners settled in October 2011.   ...
Mylan, Biocon collaborate on development, marke... [Published PBR - News - Feb 14 2013]
Mylan has partnered with Biocon for the development and commercialization of generic insulin analog products. ...
Brookings to Open Brookings India in New Delhi [Published Brookings Latest From Brookings - Jan 29 2013]
New Delhi, India – The Brookings Institution announced today that it is opening Brookings India —a centre for public policy research based in New Delhi. Brookings is making this move because of India's growing importance on the world stage as the world's ...
Pharma continues Asian Expansion & Malaysia is ... [Published Partnerships in Clinical Trials - Jan 14 2013]
Much of the talk in the Pharma industry has been the focus on the growth in the Asia Pacific region.  The country of Malaysia is no different.  According to Business Times, it's one of the fastest and stablest countries in the region, and there is ...
Pharmalot… Pharmalittle… Good Morning [Published Pharmalot - Jan 09 2013]
Rise and shine, eveyone, another busy day is on the way. And you know what that means – meetings and deadlines and phone calls! Oh my! Of course, there is an elixir for such moments – a delicious cup of stimulation. We are back to Pumpkin Spice this ...
1

Audio/Video

sort by: Date | Relevance
How Drug Makers Think About Innovation [Published WSJ.com Video - Business - Feb 20 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.